Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,232,894 papers from all fields of science
Search
Sign In
Create Free Account
Anti-HIV Agents
Known as:
Agents, Anti-AIDS
, aid drug
, Anti AIDS Drugs
Expand
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
48 relations
Narrower (40)
1,1-azobisformamide
Aldesleukin
Amprenavir
Delavirdine
Expand
AIDS therapy
Antiviral Agents
In Blood
Integrase
Expand
Broader (1)
Pharmaceutical Preparations
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
The Genus Rumex: Review of traditional uses, phytochemistry and pharmacology.
A. Vasas
,
Orsolya Orbán-Gyapai
,
J. Hohmann
Journal of ethnopharmacology
2015
Corpus ID: 42476148
Highly Cited
2014
Highly Cited
2014
Accurate Dereplication of Bioactive Secondary Metabolites from Marine-Derived Fungi by UHPLC-DAD-QTOFMS and a MS/HRMS Library
Sara Kildgaard
,
M. Månsson
,
+4 authors
K. Nielsen
Marine drugs
2014
Corpus ID: 218610270
In drug discovery, reliable and fast dereplication of known compounds is essential for identification of novel bioactive…
Expand
Highly Cited
2012
Highly Cited
2012
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
L. Khoja
,
A. Backen
,
+9 authors
C. Dive
British Journal of Cancer
2012
Corpus ID: 15175877
Background:Obtaining tissue for pancreatic carcinoma diagnosis and biomarker assessment to aid drug development is challenging…
Expand
Review
2007
Review
2007
Drug discovery for malaria: a very challenging and timely endeavor.
M. Gelb
Current opinion in chemical biology
2007
Corpus ID: 21332166
Review
2006
Review
2006
Club drugs and HIV infection: a review.
G. Colfax
,
R. Guzman
Clinical infectious diseases : an official…
2006
Corpus ID: 4672291
Club drug use is common among populations with human immunodeficiency virus (HIV) and populations at high risk for HIV infection…
Expand
Review
2005
Review
2005
Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development.
S. Whitebread
,
J. Hamon
,
D. Bojanic
,
L. Urban
Drug discovery today
2005
Corpus ID: 27303539
Highly Cited
2004
Highly Cited
2004
Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.
Darren R. March
,
Lavinia M. Proctor
,
+9 authors
D. Fairlie
Molecular pharmacology
2004
Corpus ID: 19333743
Human C5a is a plasma protein with potent chemoattractant and pro-inflammatory properties, and its overexpression correlates with…
Expand
2003
2003
Interactions of 1263W94 with Other Antiviral Agents in Inhibition of Human Cytomegalovirus Replication
D. Selleseth
,
C. Talarico
,
T. Miller
,
M. Lutz
,
K. Biron
,
R. Harvey
Antimicrobial Agents and Chemotherapy
2003
Corpus ID: 11923032
ABSTRACT Inhibition of human cytomegalovirus (HCMV) by 1263W94 was additive dosewise in combination with ganciclovir, acyclovir…
Expand
Highly Cited
2001
Highly Cited
2001
Molecular Interactions of Cyclam and Bicyclam Non-peptide Antagonists with the CXCR4 Chemokine Receptor*
L. Gerlach
,
R. Skerlj
,
G. Bridger
,
T. Schwartz
The Journal of Biological Chemistry
2001
Corpus ID: 23934847
The non-peptide CXCR4 receptor antagonist AMD3100, which is a potent blocker of human immunodeficiency virus cell entry, is a…
Expand
Highly Cited
1993
Highly Cited
1993
Roles for In Vitro Myelotoxicity Tests in Preclinical Drug Development and Clinical Trial Planning
R. Parchment
,
M. Huang
,
C. Erickson-Miller
Toxicologic pathology
1993
Corpus ID: 44733999
Myelosuppression is the dose-limiting side effect for most anti-cancer and many anti-human immunodeficiency virus agents, which…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE